Volume 10, Issue 5, Pages (February 2015)

Slides:



Advertisements
Similar presentations
Volume 16, Issue 6, Pages (August 2016)
Advertisements

Wei Liu, Kun Ma, Sun Hyung Kwon, Ravi Garg, Yoda R
Volume 41, Issue 2, Pages (January 2011)
Volume 81, Issue 1, Pages (January 2012)
Volume 33, Issue 2, Pages (January 2009)
Volume 28, Issue 3, Pages (September 2015)
Volume 59, Issue 3, Pages (August 2015)
Volume 11, Issue 6, Pages (June 2012)
Volume 13, Issue 6, Pages (June 2011)
Ying Li, Wei Xu, Michael W. McBurney, Valter D. Longo  Cell Metabolism 
Volume 22, Issue 5, Pages (May 2012)
Tie2-R849W Mutant in Venous Malformations Chronically Activates a Functional STAT1 to Modulate Gene Expression  Hsiao-Tang Hu, Yi-Hsien Huang, Yi-Ann.
Joseph T. Rodgers, Rutger O. Vogel, Pere Puigserver  Molecular Cell 
Volume 11, Issue 6, Pages (June 2010)
AMP Is a True Physiological Regulator of AMP-Activated Protein Kinase by Both Allosteric Activation and Enhancing Net Phosphorylation  Graeme J. Gowans,
A Rac-cGMP Signaling Pathway
Volume 19, Issue 3, Pages (March 2017)
Volume 20, Issue 3, Pages (September 2016)
UV-Induced RPA1 Acetylation Promotes Nucleotide Excision Repair
Volume 39, Issue 3, Pages (August 2010)
Supplement Figure 2 HEK 293 cells
Volume 56, Issue 1, Pages (October 2014)
Proline Catabolism Modulates Innate Immunity in Caenorhabditis elegans
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Volume 18, Issue 23, Pages (December 2008)
Stefanie S. Schalm, Diane C. Fingar, David M. Sabatini, John Blenis 
Volume 7, Issue 4, Pages (May 2014)
Volume 21, Issue 10, Pages (December 2017)
Volume 3, Issue 3, Pages (March 2013)
The Zinc Transporter Zip14 Influences c-Met Phosphorylation and Hepatocyte Proliferation During Liver Regeneration in Mice  Tolunay Beker Aydemir, Harry.
Volume 3, Issue 6, Pages (June 2013)
Alex M. Agelidis, Satvik R. Hadigal, Dinesh Jaishankar, Deepak Shukla 
Lisheng Ge, Ziqiu Wang, Meifang Wang, Siddhartha Kar, Brian I. Carr 
Volume 4, Issue 3, Pages (March 2015)
Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway  William A. Wilmer, Cynthia L. Dixon, Courtney Hebert 
Charlene Depry, Sohum Mehta, Ruojing Li, Jin Zhang  Chemistry & Biology 
Volume 16, Issue 6, Pages (December 2012)
Volume 53, Issue 4, Pages (February 2014)
Nucleocapsid Phosphorylation and RNA Helicase DDX1 Recruitment Enables Coronavirus Transition from Discontinuous to Continuous Transcription  Chia-Hsin.
Volume 18, Issue 11, Pages (March 2017)
Yongsheng Ma, Eric Carter, Xiaomei Wang, Chang Shu 
Kevin Takaki, Christine L. Cosma, Mark A. Troll, Lalita Ramakrishnan 
Volume 22, Issue 6, Pages (February 2018)
Volume 10, Issue 4, Pages (February 2015)
Volume 18, Issue 12, Pages (March 2017)
The Mitochondrial Rhomboid Protease PARL Is Regulated by PDK2 to Integrate Mitochondrial Quality Control and Metabolism  Guang Shi, G. Angus McQuibban 
Rsk1 mediates a MEK–MAP kinase cell survival signal
Rheb Regulates Mitophagy Induced by Mitochondrial Energetic Status
Volume 21, Issue 6, Pages (November 2017)
Volume 19, Issue 14, Pages (July 2009)
PAS Kinase Drives Lipogenesis through SREBP-1 Maturation
Volume 14, Issue 2, Pages (August 2008)
Mst1 Is an Interacting Protein that Mediates PHLPPs' Induced Apoptosis
Volume 22, Issue 6, Pages (February 2018)
Volume 17, Issue 12, Pages (December 2016)
Volume 62, Issue 4, Pages (May 2016)
Volume 16, Issue 10, Pages (September 2016)
Volume 13, Issue 1, Pages (October 2015)
Teemu P. Miettinen, Mikael Björklund  Cell Reports 
Volume 12, Issue 1, Pages (January 2019)
Volume 2, Issue 2, Pages (August 2005)
Phosphorylation of CBP by IKKα Promotes Cell Growth by Switching the Binding Preference of CBP from p53 to NF-κB  Wei-Chien Huang, Tsai-Kai Ju, Mien-Chie.
Volume 15, Issue 9, Pages (May 2016)
Allosteric Regulation of NCLX by Mitochondrial Membrane Potential Links the Metabolic State and Ca2+ Signaling in Mitochondria  Marko Kostic, Tomer Katoshevski,
Volume 28, Issue 8, Pages e4 (August 2019)
CARP2 deficiency does not alter induction of NF-κB by TNFα
Volume 12, Issue 6, Pages (March 2002)
Volume 23, Issue 12, Pages (December 2016)
Volume 9, Issue 2, Pages (October 2014)
Volume 25, Issue 11, Pages e4 (December 2018)
Presentation transcript:

Volume 10, Issue 5, Pages 694-701 (February 2015) PTPMT1 Inhibition Lowers Glucose through Succinate Dehydrogenase Phosphorylation  Anjali K. Nath, Justine H. Ryu, Youngnam N. Jin, Lee D. Roberts, Andre Dejam, Robert E. Gerszten, Randall T. Peterson  Cell Reports  Volume 10, Issue 5, Pages 694-701 (February 2015) DOI: 10.1016/j.celrep.2015.01.010 Copyright © 2015 The Authors Terms and Conditions

Cell Reports 2015 10, 694-701DOI: (10.1016/j.celrep.2015.01.010) Copyright © 2015 The Authors Terms and Conditions

Figure 1 In Vivo Chemical Screen for Modifiers of Glucose Levels Identifies Alexidine as a Glucose-Lowering Agent (A) Measurement of glucose levels in larval zebrafish after treatment with known hyper- and hypoglycemic agents (n = 3). (B) S-score (log ratio of the fold change in glucose levels) ranking of the glucose-lowering ability of compounds in the Prestwick library. Alexidine’s score is depicted in red, and its chemical structure is shown on the graph. (C) Alexidine dose-response curve (n = 5). (D–G) Bright-field (D and E) and fluorescent (F and G) images of wild-type livers (D and F) and ablated livers (E and G). (H) Glucose measurements in larvae with wild-type livers versus ablated livers. (I) Glucose measurements in alexidine-treated larvae with ablated livers (n = 3). (J–M) Bright-field (J and K) and fluorescent (L and M) images of wild-type (J and L) β cells and ablated β cells (K and M). (N) Glucose measurements in larvae with wild-type β cells versus ablated β cells. (O) Glucose measurements in alexidine-treated larvae with ablated β cells (n = 3). Data are presented as mean ± SEM. ∗p < 0.01. See also Figure S1. Cell Reports 2015 10, 694-701DOI: (10.1016/j.celrep.2015.01.010) Copyright © 2015 The Authors Terms and Conditions

Figure 2 PTPMT1 Is the Glucose-Lowering Target of Alexidine (A) Alexidine dose-response effect on PTPMT1 phosphatase activity. (B) Panel of PTPMT1 inhibitors that are structurally similar (chlorhexidine) or structurally distinct (3–6) from alexidine. (C and D) Glucose measurements in larvae treated with (C) chlorhexidine or (D) compounds 3–6. (E and F) Glucose measurements in (E) larvae injected with ptpmt1 MO or (F) wild-type (WT) versus ptpmt−/− larvae (KO). (G) Glucose measurements in ptpmt1−/− larvae treated with DMSO or alexidine. Data are presented as mean ± SEM. ∗p < 0.01. See also Figure S2. Cell Reports 2015 10, 694-701DOI: (10.1016/j.celrep.2015.01.010) Copyright © 2015 The Authors Terms and Conditions

Figure 3 SDH Is a Substrate for PTPMT1 (A) Phosphotyrosine and phosphoserine western blots on lysates from wild-type or ptpmt+/− livers. (B) Western blots from myc-SDHA-transfected INS-1E cell lysates subjected to incubation with FGR, followed by immunoprecipitation for myc and western blot for phosphotyrosine. (C) SDH enzymatic activity assay on mitochondrial lysates treated with BSA or rFGR (SD = 0.005; p < 0.0001). (D) Western blots for phospho-tyrosine and myc from lysates treated with rPTPMT1. (E) Quantification of n = 3 western blots. (F) Western blots for phosphotyrosine and myc from lysates treated with alexidine. (G) Quantification of n = 3 western blots. (H) Mitochondrial localization of SDHA in a HEK GFP-SDHA stable line. (I) Western blots of SDHA-PTPMT1 coimmunoprecipitation experiments in cells lysed with a mild detergent (DIG) versus a stronger detergent (DDM). Controls included antibody only and lysate only. The last lane contained total cell lysate. (J) Succinate levels in zebrafish larvae treated with DMSO or alexidine. (K) SDH activity in mitochondria from zebrafish larvae treated with alexidine (SD = 0.02, p = 0.0003). (L) Collectively, these studies suggest a model in which (1) alexidine inhibits the phosphatase activity of PTPMT1, (2) FGR activity leads to accumulation of the phosphorylated form of SDHA, (3) enzymatic activity of SDH increases, and (4) glucose levels decrease. Data are presented as mean ± SD. ∗p < 0.01. See also Figure S3. Cell Reports 2015 10, 694-701DOI: (10.1016/j.celrep.2015.01.010) Copyright © 2015 The Authors Terms and Conditions